Biomolecules & Therapeutics : eISSN 2005-4483 / pISSN 1976-9148

Download original image
Fig. 6. Effect of SFC on Bax protein level (A) and caspase-3-like activity (B). Control group (C) glutamate group (G), Trolox group (G+T), and SFC group (G+10, G+100 and G+500; 10, 100 and 500 μg/ml treated 1 h before glutamate treated). #p<0.05 vs. control group. *p<0.05 and **p<0.01vs glutamate.
Biomol Ther (Seoul) 2014;22:246~253 https://doi.org/10.4062/biomolther.2014.019
© Biomolecules & Therapeutics